We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion

News   May 29, 2013

 
Valeant Pharmaceuticals to Acquire Bausch + Lomb For $8.7 Billion
 
 
 

RELATED ARTICLES

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

Importance of Salt in Drug Manufacture

News

Researchers are examining how salt modifies surface interactions in chromatography, a key technique in the creation of drugs. This could be a step towards simplifying drug manufacture.

READ MORE

Converting Woodchips Into Pharmaceutical Ingredients

News

Researchers have developed a method to produce pharmaceutically relevant compounds in just a few steps – with water as the only waste product, using renewable woodchips as starting material.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE